Product NDC: | 58118-3078 |
Proprietary Name: | Cyclobenzaprine Hydrochloride |
Non Proprietary Name: | cyclobenzaprine hydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; cyclobenzaprine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 58118-3078 |
Labeler Name: | Clinical Solutions Wholesale |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077797 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070228 |
Package NDC: | 58118-3078-8 |
Package Description: | 30 TABLET, FILM COATED in 1 BLISTER PACK (58118-3078-8) |
NDC Code | 58118-3078-8 |
Proprietary Name | Cyclobenzaprine Hydrochloride |
Package Description | 30 TABLET, FILM COATED in 1 BLISTER PACK (58118-3078-8) |
Product NDC | 58118-3078 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cyclobenzaprine hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20070228 |
Marketing Category Name | ANDA |
Labeler Name | Clinical Solutions Wholesale |
Substance Name | CYCLOBENZAPRINE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |